abrdn Life Sciences Investors Other Assets

abrdn Life Sciences Investors posts a other assets of $0 as of March 2026. That compares with $410M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, abrdn Life Sciences Investors's other assets was $410M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Other Assets is one piece of abrdn Life Sciences Investors's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for HQL's other assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; abrdn Life Sciences Investors's other metric pages and overview cover the third.